Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

CollPlant Biotechnologies (CLGN) Interest Expenses (2018 - 2021)

Historic Interest Expenses for CollPlant Biotechnologies (CLGN) over the last 4 years, with Q3 2021 value amounting to -$8.0 million.

  • CollPlant Biotechnologies' Interest Expenses rose 2727.27% to -$8.0 million in Q3 2021 from the same period last year, while for Jun 2022 it was -$8.0 million, marking a year-over-year decrease of 16729.03%. This contributed to the annual value of $34000.0 for FY2020, which is 9897.06% down from last year.
  • Latest data reveals that CollPlant Biotechnologies reported Interest Expenses of -$8.0 million as of Q3 2021, which was up 2727.27% from -$8000.0 recorded in Q2 2021.
  • Over the past 5 years, CollPlant Biotechnologies' Interest Expenses peaked at $8.0 million during Q4 2020, and registered a low of -$11.0 million during Q3 2020.
  • In the last 4 years, CollPlant Biotechnologies' Interest Expenses had a median value of -$4000.0 in 2020 and averaged -$389933.3.
  • Within the past 5 years, the most significant YoY rise in CollPlant Biotechnologies' Interest Expenses was 12089.27% (2019), while the steepest drop was 2328333.33% (2019).
  • Quarter analysis of 4 years shows CollPlant Biotechnologies' Interest Expenses stood at $2.1 million in 2018, then surged by 120.89% to $4.7 million in 2019, then surged by 72.7% to $8.0 million in 2020, then crashed by 199.58% to -$8.0 million in 2021.
  • Its Interest Expenses stands at -$8.0 million for Q3 2021, versus -$8000.0 for Q2 2021 and -$19000.0 for Q1 2021.